SEARCH

SEARCH BY CITATION

References

  • Aguado C, Sarkar S, Korolchuk VI, Criado O, Vernia S, Boya P, Sanz P, de Cordoba SR, Knecht E, Rubinsztein DC (2010) Laforin, the most common protein mutated in Lafora disease, regulates autophagy. Hum Mol Genet 19: 2867- 2876
  • Barski JJ, Dethleffsen K, Meyer M (2000) Cre recombinase expression in cerebellar Purkinje cells. Genesis 28: 93- 98
  • Bestetti G, Rossi GL (1980) Hypothalamic lesions in rats with long-term streptozotocin-induced diabetes mellitus. A semiquantitative light- and electron-microscopic study. Acta Neuropathol 52: 119- 127
  • Bouskila M, Hirshman MF, Jensen J, Goodyear LJ, Sakamoto K (2008) Insulin promotes glycogen synthesis in the absence of GSK3 phosphorylation in skeletal muscle. Am J Physiol Endocrinol Metab 294: E28- E35
  • Bouskila M, Hunter RW, Ibrahim AF, Delattre L, Peggie M, van Diepen JA, Voshol PJ, Jensen J, Sakamoto K (2010) Allosteric regulation of glycogen synthase controls glycogen synthesis in muscle. Cell Metab 12: 456- 466
  • Brand AH, Perrimon N (1993) Targeted gene expression as a means of altering cell fates and generating dominant phenotypes. Development 118: 401- 415
  • Brown AM (2004) Brain glycogen re-awakened. J Neurochem 89: 537- 552
  • Brown AM, Ransom BR (2007) Astrocyte glycogen and brain energy metabolism. Glia 55: 1263- 1271
  • Cataldo AM, Broadwell RD (1986) Cytochemical identification of cerebral glycogen and glucose-6-phosphatase activity under normal and experimental conditions. II. Choroid plexus and ependymal epithelia, endothelia and pericytes. J Neurocytol 15: 511- 524
  • Cid E, Gomis RR, Geremia RA, Guinovart JJ, Ferrer JC (2000) Identification of two essential glutamic acid residues in glycogen synthase. J Biol Chem 275: 33614- 33621
  • Cid E, Cifuentes D, Baque S, Ferrer JC, Guinovart JJ (2005) Determinants of the nucleocytoplasmic shuttling of muscle glycogen synthase. FEBS J 272: 3197- 3213
  • Criado O, Aguado C, Gayarre J, Duran-Trio L, Garcia-Cabrero AM, Vernia S, San Millan B, Heredia M, Roma-Mateo C, Heredia M et al (2011) Lafora bodies and neurological defects in malin-deficient mice correlate with impaired autophagy. Hum Mol Genet 21: 1521-1533
  • Elliott DA, Brand AH (2008) The GAL4 system: a versatile system for the expression of genes. Methods Mol Biol 420: 79- 95
  • Ganesh S, Agarwala KL, Ueda K, Akagi T, Shoda K, Usui T, Hashikawa T, Osada H, Delgado-Escueta AV, Yamakawa K (2000) Laforin, defective in the progressive myoclonus epilepsy of Lafora type, is a dual-specificity phosphatase associated with polyribosomes. Hum Mol Genet 9: 2251- 2261
  • Ganesh S, Delgado-Escueta AV, Sakamoto T, Avila MR, Machado-Salas J, Hoshii Y, Akagi T, Gomi H, Suzuki T, Amano K et al (2002) Targeted disruption of the Epm2a gene causes formation of Lafora inclusion bodies, neurodegeneration, ataxia, myoclonus epilepsy and impaired behavioral response in mice. Hum Mol Genet 11: 1251- 1262
  • Gentleman RC, Carey VJ, Bates DM, Bolstad B, Dettling M, Dudoit S, Ellis B, Gautier L, Ge Y, Gentry J et al (2004) Bioconductor: open software development for computational biology and bioinformatics. Genome Biol 5: R80
  • Gentry MS, Worby CA, Dixon JE (2005) Insights into Lafora disease: malin is an E3 ubiquitin ligase that ubiquitinates and promotes the degradation of laforin. Proc Natl Acad Sci USA 102: 8501- 8506
  • Gertz HJ, Cervos-Navarro J, Frydl V, Schultz F (1985) Glycogen accumulation of the aging human brain. Mech Ageing Dev 31: 25- 35
  • Herrero-Mendez A, Almeida A, Fernandez E, Maestre C, Moncada S, Bolanos JP (2009) The bioenergetic and antioxidant status of neurons is controlled by continuous degradation of a key glycolytic enzyme by APC/C-Cdh1. Nat Cell Biol 11: 747- 752
  • Ianzano L, Zhang J, Chan EM, Zhao XC, Lohi H, Scherer SW, Minassian BA (2005) Lafora progressive myoclonus epilepsy mutation database-EPM2A and NHLRC1 (EPM2B) genes. Hum Mutat 26: 397
  • Ibrahim MZ (1972) The response of the brain to hypoxia and ischaemia. J Neurol Sci 17: 271- 279
  • Kaslow HR, Lesikar DD, Antwi D, Tan AW (1985) L-type glycogen synthase. Tissue distribution and electrophoretic mobility. J Biol Chem 260: 9953- 9956
  • Koizumi J, Shiraishi H, Minei S (1970) Ultrastructural appearance of glycogen in neuron and astrocyte of the human cerebral cortex adjacent to brain tumors. J Electron Microsc (Tokyo) 19: 355- 359 passim
  • Leel-Ossy L (1995) The occurrence of corpus amylaceum (polyglucosan body) in diabetes mellitus. Neuropathology 15: 108- 111
  • Long DM, Mossakowski MJ, Klatzo I (1972) Glycogen accumulation in spinal cord motor neurons due to partial ischemia. Acta Neuropathol 20: 335- 347
  • Magistretti PJ, Allaman I (2007) Glycogen: a Trojan horse for neurons. Nat Neurosci 10: 1341- 1342
  • McGuire SE, Mao Z, Davis RL (2004) Spatiotemporal gene expression targeting with the TARGET and gene-switch systems in Drosophila. Sci STKE 2004: pl6
  • Moore SA, Peterson RG, Felten DL, O'Connor BL (1981) Glycogen accumulation in tibial nerves of experimentally diabetic and aging control rats. J Neurol Sci 52: 289- 303
  • Powell H, Knox D, Lee S, Charters AC, Orloff M, Garrett R, Lampert P (1977) Alloxan diabetic neuropathy: electron microscopic studies. Neurology 27: 60- 66
  • Puri R, Ganesh S (2010) Laforin in autophagy: a possible link between carbohydrate and protein in Lafora disease? Autophagy 6: 1229- 1231
  • Roach PJ, Cheng C, Huang D, Lin A, Mu J, Skurat AV, Wilson W, Zhai L (1998) Novel aspects of the regulation of glycogen storage. J Basic Clin Physiol Pharmacol 9: 139- 151
  • Schaefer A, O'Carroll D, Tan CL, Hillman D, Sugimori M, Llinas R, Greengard P (2007) Cerebellar neurodegeneration in the absence of microRNAs. J Exp Med 204: 1553- 1558
  • Tay SS, Wong WC (1991) Ultrastructural changes in the gracile nucleus of the spontaneously diabetic BB rat. Histol Histopathol 6: 43- 53
  • Tronche F, Kellendonk C, Kretz O, Gass P, Anlag K, Orban PC, Bock R, Klein R, Schutz G (1999) Disruption of the glucocorticoid receptor gene in the nervous system results in reduced anxiety. Nat Genet 23: 99- 103
  • Turnbull J, DePaoli-Roach AA, Zhao X, Cortez MA, Pencea N, Tiberia E, Piliguian M, Roach PJ, Wang P, Ackerley CA et al (2011) PTG depletion removes Lafora bodies and rescues the fatal epilepsy of Lafora disease. PLoS Genet 7: e1002037
  • Valles-Ortega J, Duran J, Garcia-Rocha M, Bosch C, Saez I, Pujadas L, Serafin A, Canas X, Soriano E, Delgado-Garcia JM et al (2011) Neurodegeneration and functional impairments associated with glycogen synthase accumulation in a mouse model of Lafora disease. EMBO Mol Med 3: 667- 681
  • Vernia S, Rubio T, Heredia M, Rodriguez de Cordoba S, Sanz P (2009) Increased endoplasmic reticulum stress and decreased proteasomal function in Lafora disease models lacking the phosphatase laforin. PLoS One 4: e5907
  • Vilchez D, Ros S, Cifuentes D, Pujadas L, Valles J, Garcia-Fojeda B, Criado-Garcia O, Fernandez-Sanchez E, Medrano-Fernandez I, Dominguez J et al (2007) Mechanism suppressing glycogen synthesis in neurons and its demise in progressive myoclonus epilepsy. Nat Neurosci 10: 1407- 1413
  • Wender R, Brown AM, Fern R, Swanson RA, Farrell K, Ransom BR (2000) Astrocytic glycogen influences axon function and survival during glucose deprivation in central white matter. J Neurosci 20: 6804- 6810